Erudio Healtherudio.com
Sponsor
Alliance for Clinical Trials in Oncology trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Alliance for Clinical Trials in Oncology yet. Erudio has found public clinician commentary on 16 clinical trials sponsored by Alliance for Clinical Trials in Oncology, including A-DREAM, ACOSOG Z0011, CALGB 10403 and CALGB/SWOG 80702. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Alliance for Clinical Trials in Oncology). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CALGB 10403 NCT00558519 · Alliance for Clinical Trials in Oncology DeepView → | newly diagnosed ALL in adolescents and young adults | Phase 2 | Deep | View | |||
| CALGB/SWOG 80702 NCT01150045 · Alliance for Clinical Trials in Oncology DeepView → | resected stage III colon cancer | Phase 3 | Deep | View | |||
| A-DREAM NCT05241860 · Alliance for Clinical Trials in Oncology DeepView → | metastatic hormone-sensitive prostate cancer | Phase 2 | Deep | View | |||
| ACOSOG Z0011 NCT00003855 · Alliance for Clinical Trials in Oncology DeepView → | invasive breast cancer with sentinel node metastasis | Phase 3 | Deep | View | |||
| BWEL NCT02750826 · Alliance for Clinical Trials in Oncology DeepView → | overweight and obese women with early breast cancer | Phase 3 | Deep | View | |||
| Alliance A021501 NCT02839343 · Alliance for Clinical Trials in Oncology DeepView → | borderline resectable pancreatic adenocarcinoma | Phase 2 | Deep | View | |||
| CALGB 50303 NCT00118209 · Alliance for Clinical Trials in Oncology DeepView → | untreated diffuse large B-cell lymphoma | Phase 3 | Deep | View | |||
| compassHER2 RD NCT04457596 · Alliance for Clinical Trials in Oncology StandardView → | residual HER2-positive invasive breast cancer | Phase 3 | Standard | View | |||
| A031701 NCT03609216 · Alliance for Clinical Trials in Oncology StandardView → | muscle-invasive bladder urothelial cancer | Phase 2 | Standard | View | |||
| CALGB 30610 NCT00632853 · Alliance for Clinical Trials in Oncology StandardView → | limited-stage small cell lung cancer | Phase 3 | Standard | View | |||
| A022004 NCT05710406 · Alliance for Clinical Trials in Oncology FocusedView → | stage II/III BRAF V600E colon cancer | Phase 2/Phase 3 | Focused | View | |||
| NCT01336894 NCT01336894 · Alliance for Clinical Trials in Oncology FocusedView → | high-risk stage I non-small cell lung cancer | Phase 3 | Focused | View | |||
| ComPareNET NCT05247905 · Alliance for Clinical Trials in Oncology FocusedView → | advanced well-differentiated pancreatic neuroendocrine tumors | Phase 2 | Focused | View | |||
| A022101 NCT05673148 · Alliance for Clinical Trials in Oncology FocusedView → | limited metastatic colorectal cancer | Phase 2 | Focused | View | |||
| STRIKE NCT06661720 · Alliance for Clinical Trials in Oncology FocusedView → | Not given | Phase 3 | Focused | View | |||
| GAIN-BCG NCT07000084 · Alliance for Clinical Trials in Oncology FocusedView → | recurrent BCG-exposed high-grade non-muscle-invasive bladder cancer | Phase 3 | Focused | View | |||